1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Pharmacogenomics Market – By Technology

1.3.2        North America Pharmacogenomics Market – By Application

1.3.3        North America Pharmacogenomics Market – By End User

1.3.4        North America Pharmacogenomics Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Pharmacogenomics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America PEST Analysis

4.3         Experts Opinion

5.           Pharmacogenomics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Chronic Diseases

5.1.2        Growing Funding for Pharmacogenomics

5.2         Market Restraints

5.2.1        Lack of Skilled Professionals

5.3         Market Opportunities

5.3.1        Increasing Demand for Third Generation Sequencing

5.4         Future Trends

5.4.1        Increasing Demand for Personalized Medicines

6.           Pharmacogenomics Market– North America Analysis

6.1         North America Pharmacogenomics Market Revenue Forecast and Analysis

7.           Pharmacogenomics Market Revenue and Forecasts To 2028 – Technology

7.1         Overview

7.2         Pharmacogenomics Market Share by Technology - 2021 & 2028 (%)

7.3         Polymerase Chain Reaction

7.3.1        Overview

7.3.2        Polymerase Chain Reaction: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.3.3        Real Time PCR

7.3.3.1          Overview

7.3.3.2          Real Time PCR: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.3.4        Standard PCR

7.3.4.1          Overview

7.3.4.2          Standard PCR: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.3.5        Digital PCR

7.3.5.1          Overview

7.3.5.2          Digital PCR: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.4         Sequencing

7.4.1        Overview

7.4.2        Sequencing: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.5         Microarray

7.5.1        Overview

7.5.2        Microarray: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.6         Gel Electrophoresis

7.6.1        Overview

7.6.2        Gel Electrophoresis: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.7         Mass Spectrometry

7.7.1        Overview

7.7.2        Mass Spectrometry: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.8         Others

7.8.1        Overview

7.8.2        Others: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8.           North America Pharmacogenomics Market Revenue and Forecasts To 2028– by Application

8.1         Overview

8.2         Pharmacogenomics Market Share by Application- 2021 & 2028 (%)

8.3         Drug Discovery

8.3.1        Overview

8.3.2        Drug Discovery: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8.4         Oncology

8.4.1        Overview

8.4.2        Oncology: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8.5         Neurology & Psychiatry

8.5.1        Overview

8.5.2        Neurology & Psychiatry: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8.6         Pain Management

8.6.1        Overview

8.6.2        Pain Management: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8.7         Cardiovascular Disease

8.7.1        Overview

8.7.2        Cardiovascular Disease: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8.8         Others

8.8.1        Overview

8.8.2        Others: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

9.           Pharmacogenomics Market Revenue and Forecasts To 2028 – End User

9.1         Overview

9.2         Pharmacogenomics Market Share by End User - 2021 & 2028 (%)

9.3         Hospitals and Clinics

9.3.1        Overview

9.3.2        Hospitals and Clinics: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

9.4         Biopharmaceutical Companies

9.4.1        Overview

9.4.2        Biopharmaceuticals Companies: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

9.5         CROs and CDMOs

9.5.1        Overview

9.5.2        CROs and CDMOs: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

9.6         Others

9.6.1        Overview

9.6.2        Others: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

10.        Pharmacogenomics Market Revenue and Forecasts to 2028 –Country Analysis

10.1      North America: Pharmacogenomics Market

10.1.1     Overview

10.1.2     North America: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3     North America: Pharmacogenomics Market, by Technology, 2019–2028 (US$ Million)

10.1.3.1       North America: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.1.4     North America: Pharmacogenomics Market, by Application, 2019–2028 (US$ Million)

10.1.5     North America: Pharmacogenomics Market, by End-User, 2019–2028 (US$ Million)

10.1.6     North America: Pharmacogenomics Market, by Country, 2021 & 2028 (%)

10.1.6.1       US: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.1       Overview

10.1.6.1.2       US: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.3       US: Pharmacogenomics Market, by Technology, 2019–2028 (US$ Million)

10.1.6.1.3.1    US: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.1.6.1.4       US: Pharmacogenomics Market, by Application, 2019–2028 (US$ Million)

10.1.6.1.5       US: Pharmacogenomics Market, by End-User, 2019–2028 (US$ Million)

10.1.6.2       Canada: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.1       Overview

10.1.6.2.2       Canada: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.3       Canada: Pharmacogenomics Market, by Technology, 2019–2028 (US$ Million)

10.1.6.2.3.1    Canada: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.1.6.2.4       Canada: Pharmacogenomics Market, by Application, 2019–2028 (US$ Million)

10.1.6.2.5       Canada: Pharmacogenomics Market, by End-User, 2019–2028 (US$ Million)

10.1.6.3       Mexico: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.1       Overview

10.1.6.3.2       Mexico: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.3       Mexico: Pharmacogenomics Market, by Technology, 2019–2028 (US$ Million)

10.1.6.3.3.1    Mexico: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.1.6.3.4       Mexico: Pharmacogenomics Market, by Application, 2019–2028 (US$ Million)

10.1.6.3.5       Mexico: Pharmacogenomics Market, by End-User, 2019–2028 (US$ Million)

11.        Impact of COVID-19 Pandemic on North America Pharmacogenomics Market

11.1      North America: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Abbott

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      F. HOFFMANN-LA ROCHE LTD.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Oxford Nanopore Technologies

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      THERMO FISHER SCIENTIFIC INC.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Illumina, Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      QIAGEN

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Agilent Technologies, Inc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Myriad Genetics, Inc.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Admera Health

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Dynamic DNA Laboratories

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 2.             North America: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 3.             North America Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 4.             US Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 5.             US Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 6.             US Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 7.             US Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Canada: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Canada: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 10.          Canada Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 11.          Canada Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Mexico: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Mexico: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 14.          Mexico Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 15.          Mexico Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Organic Developments Done By Companies

Table 17.          Inorganic Developments Done By Companies

Table 18.          Glossary of Terms

LIST OF FIGURES

Figure 1.           Pharmacogenomics Market Segmentation

Figure 2.           Pharmacogenomics Market, By Country

Figure 3.           North America Pharmacogenomics Market Overview

Figure 4.           PCR Segment Held Largest Share of Technology Segment in Pharmacogenomics Market

Figure 5.           North America Pharmacogenomics Market- Leading Country Markets (US$ Million)

Figure 6.           North America: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           North America Pharmacogenomics Market– Revenue Forecast and Analysis – 2021 - 2028

Figure 9.           Pharmacogenomics Market Share by Segment - 2021 & 2028 (%)

Figure 10.        Polymerase Chain Reaction: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 11.        Real Time PCR: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 12.        Standard PCR: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 13.        Digital PCR: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 14.        Sequencing: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 15.        Microarray: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 16.        Gel Electrophoresis: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17.        Mass Spectrometry: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 18.        Others: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19.        Pharmacogenomics Market Share by Application- 2021 & 2028 (%)

Figure 20.        Drug Discovery: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21.        Oncology: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22.        Neurology & Psychiatry: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 23.        Pain Management: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 24.        Cardiovascular Disease: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25.        Others: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26.        Pharmacogenomics Market Share by End User - 2021 & 2028 (%)

Figure 27.        Hospital and Clinics: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 28.        Biopharmaceutical Companies: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 29.        CROs and CDMOs: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 30.        Others: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 31.        North America: Pharmacogenomics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 32.        North America Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

Figure 33.        North America: Pharmacogenomics Market, by Country, 2021 & 2028 (%)

Figure 34.        US: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Canada: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.        Mexico: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37.        Impact of COVID-19 Pandemic in North America Country Markets